Adjuvant therapy for esophageal squamous cell carcinoma

Jong Mu Sun

doi:10.5090/kjtcs.2020.53.4.168

Adjuvant therapy for esophageal squamous cell carcinoma

Jong Mu Sun

Sungkyunkwan University

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Adjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise review of the evidence regarding adjuvant therapy for esophageal squamous cell carcinoma and future directions, particularly immunotherapy.

Original language	English
Pages (from-to)	168-171
Number of pages	4
Journal	Korean Journal of Thoracic and Cardiovascular Surgery
Volume	53
Issue number	4
DOIs	https://doi.org/10.5090/kjtcs.2020.53.4.168
State	Published - 1 Aug 2020
Externally published	Yes

Keywords

Adjuvant therapy
Esophageal neoplasms
Immunotherapy
Neoadjuvant therapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.5090/kjtcs.2020.53.4.168

Cite this

@article{8f4c29564a9d4436911b63c07cd93528,

title = "Adjuvant therapy for esophageal squamous cell carcinoma",

abstract = "Adjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise review of the evidence regarding adjuvant therapy for esophageal squamous cell carcinoma and future directions, particularly immunotherapy.",

keywords = "Adjuvant therapy, Esophageal neoplasms, Immunotherapy, Neoadjuvant therapy",

author = "Sun, \{Jong Mu\}",

note = "Publisher Copyright: {\textcopyright} the korean society for thoracic and cardiovascular surgery. 2020.",

year = "2020",

month = aug,

day = "1",

doi = "10.5090/kjtcs.2020.53.4.168",

language = "English",

volume = "53",

pages = "168--171",

journal = "Korean Journal of Thoracic and Cardiovascular Surgery",

issn = "2233-601X",

publisher = "Korean Society for Thoracic and Cardiovascular Surgery",

number = "4",

}

TY - JOUR

T1 - Adjuvant therapy for esophageal squamous cell carcinoma

AU - Sun, Jong Mu

N1 - Publisher Copyright: © the korean society for thoracic and cardiovascular surgery. 2020.

PY - 2020/8/1

Y1 - 2020/8/1

N2 - Adjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise review of the evidence regarding adjuvant therapy for esophageal squamous cell carcinoma and future directions, particularly immunotherapy.

AB - Adjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise review of the evidence regarding adjuvant therapy for esophageal squamous cell carcinoma and future directions, particularly immunotherapy.

KW - Adjuvant therapy

KW - Esophageal neoplasms

KW - Immunotherapy

KW - Neoadjuvant therapy

UR - https://www.scopus.com/pages/publications/85089336928

U2 - 10.5090/kjtcs.2020.53.4.168

DO - 10.5090/kjtcs.2020.53.4.168

M3 - Article

AN - SCOPUS:85089336928

SN - 2233-601X

VL - 53

SP - 168

EP - 171

JO - Korean Journal of Thoracic and Cardiovascular Surgery

JF - Korean Journal of Thoracic and Cardiovascular Surgery

IS - 4

ER -

Adjuvant therapy for esophageal squamous cell carcinoma

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this